Author

C. W. White

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:protein folding & dynamics· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1

Frequent Co-Authors

S. J. Hill· 3 shared K. D. Pfleger· 2 shared A. Bosco-Lauth· 1 shared A. O. Khan· 1 shared A. Slater· 1 shared D. M. Hinds· 1 shared E. H. Cooper· 1 shared H. J. Nick· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

S. J. Hill

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Acute Vaping of a golden Syrian Hamster is Feasible and Leads to Nicotine-Dependent Respiratory Tract Inflammation

D. M. Hinds, H. J. Nick, T. M. Vallin, L. A. Bloomquist, S. Christeson, P. E. Bratcher, E. H. Cooper, J. T. Brinton, A. Bosco-Lauth, C. W. White

This study shows that acute vaping in golden Syrian hamsters causes respiratory tract inflammation and upregulates genes related to inflammation, fibrosis, and coagulation.

bioRxiv · May 20, 2022 · PreprintPharmacology & Toxicology

CXCL17 is an endogenous inhibitor of CXCR4 via a novel mechanism of action

C. W. White, L. E. Kilpatrick, N. Dale, R. S. Abhayawardana, S. Dekkers, M. J. Stocks, K. D. Pfleger, S. J. Hill

This study identifies CXCL17 as an endogenous inhibitor of CXCR4 through a novel mechanism involving interaction with neuropillin-1 and glycosaminoglycan binders.

bioRxiv · Jul 5, 2021 · PreprintPharmacology & Toxicology

A Nanoluciferase biosensor to investigate endogenous chemokine secretion and receptor binding.

C. W. White, K. D. Pfleger, S. J. Hill

This paper develops a Nanoluciferase biosensor to quantify and monitor chemokine secretion and receptor binding in live cells.

bioRxiv · Aug 19, 2020Pharmacology & Toxicology

Optimised CRISPR-Cas9 mediated single molecule imaging for accurate quantification through endogenous expression.

A. O. Khan, C. W. White, J. A. Pike, J. Yule, A. Slater, S. J. Hill, N. S. Poulter, S. G. Thomas, N. V. Morgan

This study optimizes CRISPR-Cas9 for single molecule imaging by improving mEos variants and shows endogenous labeling enables accurate quantification of CXCR4.

bioRxiv · Nov 30, 2018 · PreprintCell Biology